Collagen News and Research RSS Feed - Collagen News and Research

Researchers discover new natural tooth repair method using Alzheimer's drug

Researchers discover new natural tooth repair method using Alzheimer's drug

A new method of stimulating the renewal of living stem cells in tooth pulp using an Alzheimer's drug has been discovered by a team of researchers at King's College London. [More]
FDA-approved, bioengineered living-cell therapy can shift genomic profile of non-healing wounds

FDA-approved, bioengineered living-cell therapy can shift genomic profile of non-healing wounds

Apligraf - an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. - has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a treated non-healing wound, according to new research published in the peer-reviewed journal Science Translational Medicine. [More]
MMP9 enzyme could suppress tumors in colitis associated cancer, new study finds

MMP9 enzyme could suppress tumors in colitis associated cancer, new study finds

An enzyme that plays an active role in inflammation could be a natural way to suppress tumors and ulcers in the colon that are found in colitis associated cancer (CAC), a type of colorectal cancer that is driven by chronic inflammation, according to a new study. [More]
Nanohyperthermia may prove effective as adjuvant cancer treatment with chemotherapy

Nanohyperthermia may prove effective as adjuvant cancer treatment with chemotherapy

The mechanical resistance of tumors and collateral damage of standard treatments often hinder efforts to defeat cancers. [More]
Rice bioengineers reveal how heart valves use different strategies to handle oxygen starvation

Rice bioengineers reveal how heart valves use different strategies to handle oxygen starvation

As the valves in a heart stretch with each beat, their cells take in life-giving oxygen. But if the supply is cut off, aortic and mitral valves use different strategies to compensate, according to Rice University scientists. [More]
Research finds differences in cell migration between normal and malignant tumor cells

Research finds differences in cell migration between normal and malignant tumor cells

What makes cancer so deadly is its ability to move . The better that doctors can keep tumors contained and protect unaffected organs in the body, the less lethal a cancer will be. [More]
Gelatin supplement consumption plus intensive exercise can help build ligaments, tendons and bones

Gelatin supplement consumption plus intensive exercise can help build ligaments, tendons and bones

A new study from Keith Baar's Functional Molecular Biology Laboratory at the UC Davis College of Biological Sciences and the Australian Institute of Sport suggests that consuming a gelatin supplement, plus a burst of intensive exercise, can help build ligaments, tendons and bones. [More]
Novel approach can regenerate dental pulp-like tissues in animal model

Novel approach can regenerate dental pulp-like tissues in animal model

When a tooth is damaged, either by severe decay or trauma, the living tissues that comprise the sensitive inner dental pulp become exposed and vulnerable to harmful bacteria. [More]
Curasan reveal plan for orthopedic product campaign

Curasan reveal plan for orthopedic product campaign

Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States. [More]
Study identifies conditions required to further develop liver and pancreas cells

Study identifies conditions required to further develop liver and pancreas cells

AMSBIO reports on the recent publication in Nature Protocols1 by Dr Meritxell Huch** and co-workers which describes development of culture conditions that allow the long-term expansion of adult primary tissues from the liver and pancreas into self-assembling 3D organoid cultures. [More]
IQWiG finds both hint of benefit and harm from corneal collagen cross-linking for keratoconus

IQWiG finds both hint of benefit and harm from corneal collagen cross-linking for keratoconus

In patients with keratoconus the cornea of the eye begins to bulge. So-called corneal collagen cross-linking aims to halt this process. In this procedure, the cornea is stiffened through locally applied vitamin B2 in combination with UVA radiation. [More]
MGH researchers develop new methods for mapping and measuring solid stress in tumors

MGH researchers develop new methods for mapping and measuring solid stress in tumors

Massachusetts General Hospital investigators have developed new methods for mapping and measuring solid stress - the force exerted by solid and elastic components - within tumors, an accomplishment that may lead to improved understanding of those forces and their consequences and to novel treatment strategies. [More]

RIT scientists to explore properties of vitreous gel to find clues for vision disorders

Research is underway at Rochester Institute of Technology that will give scientists a better understanding of the vitreous humor, or gel, that fills the eye and could lead to advances in the treatment of vision disorders, drug delivery and eye surgery. [More]
Pitt researcher finds way to regenerate heart tissues in mammals

Pitt researcher finds way to regenerate heart tissues in mammals

Many lower forms of life on earth exhibit an extraordinary ability to regenerate tissue, limbs, and even organs--a skill that is lost among humans and other mammals. [More]
Nature article highlights use of QGel's designer matrices for intestinal and colorectal cancer organoid culture

Nature article highlights use of QGel's designer matrices for intestinal and colorectal cancer organoid culture

Nature, the leading weekly international scientific journal, yesterday reported the first intestinal and colorectal cancer organoid culture in fully defined extra cellular matrices (ECM). [More]
Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting

Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting

Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem’s unique and multifaceted mode of action. [More]
Lonza’s RAFT 3D Cell Culture System helps researchers develop corneal models for research into blindness treatment

Lonza’s RAFT 3D Cell Culture System helps researchers develop corneal models for research into blindness treatment

Lonza’s RAFT 3D Cell Culture System has been used to develop corneal models for research into treatment for a painful and potentially blinding corneal disease. [More]
BUSM researchers show how MRI can effectively identify bone marrow cancer in experimental model

BUSM researchers show how MRI can effectively identify bone marrow cancer in experimental model

For the first time, researchers have shown that using Magnetic Resonance Imaging (MRI) can effectively identify bone marrow cancer (myelofibrosis) in an experimental model. [More]
New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

New study identifies novel target for treatment of Graves' disease and other scarring eye conditions

A new class of therapies may be on the horizon for thyroid eye disease (TED) and other destructive scarring conditions. [More]
Aortic rigidity in African-Americans linked to excess risk of hypertension and cardiovascular disease

Aortic rigidity in African-Americans linked to excess risk of hypertension and cardiovascular disease

African-Americans have more rigidity of the aorta, the major artery supplying oxygen-rich blood to the body, than Caucasians and Hispanics, according to a study by UT Southwestern Medical Center cardiologists. [More]
Advertisement
Advertisement